ClaimsDemis Hassabis

“Proud of our latest work applying AI to Quantum Chemistry published in @ScienceMagazine!”

Demis Hassabis, on X 10 December 2021 Post by @demishassabis on X, 2021-12-10 (X)

Factual Science and research methods

DeepMind has published work applying AI to quantum chemistry in Science magazine.

Resolved true The record shows it happened or was so.

Factual: Statements about the present or the past, checked against the record: did they hold up?

Said for an organisation they lead or work for; it counts on both records.

What would count as true or false

True: on or shortly before 2021-12-10, Science published a DeepMind paper applying AI to quantum chemistry (for example the DM21 density functional paper, 'Pushing the frontiers of density functionals by solving the fractional electron problem'). Mostly true: the paper appeared in Science, but the date or a small detail differs slightly. Mostly false: the work was published in a different journal or only as a preprint. False: no such DeepMind paper was published in Science.

Set before the research began.

Evidence (3)

  1. E1 DeepMind neural networks open new window to understanding electron interactions EurekAlert! · 9 December 2021

    “Journal Science Article Title Pushing the Frontiers of Density Functionals by Solving the Fractional Electron Problem Article Publication Date 10-Dec-2021”
  2. E2 DeepMind neural networks open new window to understanding electron interactions EurekAlert! · 9 December 2021

    “Neural networks can be used to build a more accurate map of the density and interaction between electrons than was previously attainable, new research from DeepMind shows.”
  3. E3 Simulating matter on the quantum scale with AI DeepMind · 9 December 2021 Own record

    “Now, in a paper (Open Access PDF) published in Science, we propose DM21, a neural network achieving state of the art accuracy on large parts of chemistry.”

Reasoning

E1, an independent EurekAlert! release, gives the journal as Science, the article title as 'Pushing the Frontiers of Density Functionals by Solving the Fractional Electron Problem' and the publication date as 10 December 2021. E2 says this is new DeepMind research that uses neural networks to model electron density and interactions, which is AI applied to quantum chemistry. DeepMind's own blog post (E3) agrees that the DM21 paper was published in Science. This matches the true criterion.

Cite this claim

Demis Hassabis, “DeepMind has published work applying AI to quantum chemistry in Science magazine.” (said 10 December 2021). Verdict: resolved true. Reliability API, claim c_6e2100f7c250, method 0.1.0+c876030c, dataset release v1.1.2. https://epistacklabs.com/claims/c_6e2100f7c250

This claim is in dataset release v1.1.2, with the same verdict.

Reply to this claim

For Demis Hassabis, or someone speaking for them: a correction or counter-evidence. Replies are read before anything is shown; an approved reply shows your name, role, date, statement and link. Your email address is never shown and is deleted 30 days after the decision (privacy).

More factual claims by Demis Hassabis

  1. Mostly true Factual 10 April 2026
    “what’s important about them is their 3D structure.”

    A protein's 3D structure is what determines, or partially determines, its function.

  2. Resolved true Factual 10 April 2026
    “So over 3 million scientists are now using AlphaFold.”

    Over 3 million scientists are now using AlphaFold.

  3. Resolved true Factual 10 April 2026
    “Only about 10% of drugs actually get through all the clinical stages.”

    Only about 10% of drugs get through all the clinical stages.

  4. Mostly true Factual 25 November 2025
    “The AlphaFold Server is empowering non-commercial researchers globally to harness this technology, accelerating their ability to formulate and test new hypotheses.”

    The AlphaFold Server is available to non-commercial researchers globally for predicting structures and interactions.

  5. Mostly true Factual 25 November 2025
    “Our AlphaProteo model can design novel, high-strength protein binders that target diverse molecules – including those associated with cancer and diabetes.”

    AlphaProteo can design novel, high-strength protein binders targeting diverse molecules, including ones associated with cancer and diabetes.

All of them

Verdicts are made automatically; how verdicts are made.